Optimization of dose regimen for chronically administered drugs with population pharmacokinetic methods

Projektinformationen

JOHN C LUKAS

ID Finanzhilfevereinbarung: HPMF-CT-2002-01922

Startdatum 1 September 2002

Enddatum 31 August 2003

Finanziert unter

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Gesamtkosten € 76 000,00

EU-Beitrag € 76 000,00

Koordiniert durch

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS
Greece

Ziel

State of the art "population"' pharmacokinetic analysis is used to explain and predict the interindividual variability of three costly and chronically administered immunosuppressants, antineoplasic and antiepileptic drugs.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmacokinetics

Programm/Programme

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS

• EU-Beitrag: Keine Daten
• Adresse: Panepistimiopolis ; 15771 ATHENS ; Griechenland
• Gesamtkosten: Keine Daten